Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025
Penumbra (NYSE: PEN) has scheduled its second quarter 2025 earnings conference call for July 29, 2025, at 4:30 PM Eastern Time. The company will release its Q2 2025 financial results after market close on the same day.
Investors can access the conference call by dialing (888) 596-4144 with conference ID 6572573, or via webcast through the "Events and Presentations" section on Penumbra's website. The webcast recording will remain available for at least two weeks after the call.
Penumbra (NYSE: PEN) ha programmato la conference call sui risultati del secondo trimestre 2025 per il 29 luglio 2025 alle 16:30 ora Eastern. La società pubblicherà i risultati finanziari del Q2 2025 dopo la chiusura del mercato nello stesso giorno.
Gli investitori potranno partecipare alla conference call chiamando il numero (888) 596-4144 con ID conferenza 6572573, oppure tramite webcast nella sezione "Eventi e Presentazioni" del sito web di Penumbra. La registrazione del webcast sarà disponibile per almeno due settimane dopo la chiamata.
Penumbra (NYSE: PEN) ha programado su llamada de conferencia de resultados del segundo trimestre de 2025 para el 29 de julio de 2025 a las 4:30 PM hora del Este. La compañÃa publicará sus resultados financieros del Q2 2025 después del cierre del mercado ese mismo dÃa.
Los inversores podrán acceder a la llamada marcando al (888) 596-4144 con el ID de conferencia 6572573, o a través de la transmisión en vivo en la sección "Eventos y Presentaciones" del sitio web de Penumbra. La grabación del webcast estará disponible al menos dos semanas después de la llamada.
Penumbra (NYSE: PEN)ëŠ� 2025ë…� 2분기 실ì 컨í¼ëŸ°ìФ ì½œì„ 2025ë…� 7ì›� 29ì� 오후 4ì‹� 30ë¶�(ë™ë¶€ 시간)ì—� ì˜ˆì •í•˜ê³ ìžˆìŠµë‹ˆë‹¤. 회사ëŠ� ê°™ì€ ë‚� 시장 ë§ˆê° í›� 2025ë…� 2분기 재무 실ì ì� 발표í•� ì˜ˆì •ìž…ë‹ˆë‹�.
투ìžìžë“¤ì¶Ä (888) 596-4144번으ë¡� 컨í¼ëŸ°ìФ ID 6572573ë¥� ìž…ë ¥í•˜ì—¬ 컨í¼ëŸ°ìФ ì½œì— ì°¸ì—¬í•˜ê±°ë‚�, Penumbra 웹사ì´íЏì� "ì´ë²¤íŠ� ë°� 발표" 섹션ì� 통해 웹ìºìŠ¤íŠ¸ë¡� ì ‘ì†í•� ìˆ� 있습니다. 웹ìºìŠ¤íŠ¸ 녹화ëŠ� ì½� ì´í›„ 최소 2주간 ì œê³µë©ë‹ˆë‹�.
Penumbra (NYSE : PEN) a programmé sa conférence téléphonique sur les résultats du deuxième trimestre 2025 pour le 29 juillet 2025 à 16h30 heure de l'Est. La société publiera ses résultats financiers du T2 2025 après la clôture des marchés le même jour.
Les investisseurs peuvent accéder à la conférence téléphonique en composant le (888) 596-4144 avec l’identifiant de conférence 6572573, ou via un webcast dans la section « Événements et Présentations » du site web de Penumbra. L’enregistrement du webcast restera disponible pendant au moins deux semaines après la conférence.
Penumbra (NYSE: PEN) hat seine Telefonkonferenz für die Ergebnisse des zweiten Quartals 2025 für den 29. Juli 2025 um 16:30 Uhr Eastern Time angesetzt. Das Unternehmen wird seine Finanzergebnisse für das zweite Quartal 2025 am selben Tag nach Börsenschluss veröffentlichen.
Investoren können an der Telefonkonferenz teilnehmen, indem sie die Nummer (888) 596-4144 mit der Konferenz-ID 6572573 wählen oder über einen Webcast im Bereich „Veranstaltungen und Präsentationen� auf der Website von Penumbra zugreifen. Die Aufzeichnung des Webcasts wird mindestens zwei Wochen nach dem Anruf verfügbar sein.
- None.
- None.
Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 6572573), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at . The webcast will be available on the Company's website for at least two weeks following the completion of the call.
About Penumbra
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit and connect on , and .
Investor Relations
Penumbra, Inc.
[email protected]Ìý
View original content to download multimedia:
SOURCE Penumbra, Inc.